Journal Article

Essential Hypertension and Oxidative Stress: Novel Future Perspectives

Bonomini, Francesca, Sciatti, Edoardo, Vizzardi, Enrico, Rezzani, Rita, Franco, Caterina, Favero, Gaia

2022

Overview

Among cardiovascular diseases, hypertension is one of the main risk factors predisposing to fatal complications. Oxidative stress and chronic inflammation have been identified as potentially responsible for the development of endothelial damage and vascular stiffness, two of the primum movens of hypertension and cardiovascular diseases. Based on these data, we conducted an open-label randomized study, first, to evaluate the endothelial damage and vascular stiffness in hypertense patients; second, to test the effect of supplementation with a physiological antioxidant (melatonin 1 mg/day for 1 year) in patients with essential hypertension vs. hypertensive controls. Twenty-three patients of either gender were enrolled and randomized 1:1 in two groups (control and supplemented group). The plasmatic total antioxidant capacity (as a marker of oxidative stress), blood pressure, arterial stiffness, and peripheral endothelial function were evaluated at the beginning of the study and after 1 year in both groups. Our results showed that arterial stiffness improved significantly (p = 0.022) in supplemented patients. The endothelial function increased too, even if not significantly (p = 0.688), after 1 year of melatonin administration. Moreover, the supplemented group showed a significative reduction in TAC levels (p = 0.041) correlated with the improvement of arterial stiffness. These data suggest that melatonin may play an important role in reducing the serum levels of TAC and, consequently, in improving arterial stiffness.

• Publisher: MDPI AG,MDPI
• Subject: Antihypertensives / Antioxidants / Antioxidants - therapeutic use / Blood pressure / Body mass index / Cardiovascular Diseases / Essential Hypertension / Hemodynamics / Humans / Hypertension / Males / Melatonin / Melatonin - therapeutic use / Oxidative Stress